Aziyo Biologics


Established in 2015, Aziyo Biologics is a privately-held, commercially-oriented biotech company focused on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties
Since its founding, the Company has expanded through a combination of acquisitions and strategic partnerships, creating a high-growth commercial entity. Our mission is to restore health and mobility through the development of innovative new solutions that expand the possibilities of regenerative medicine.

Showing all 3 results

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.